This is an exciting time to be involved in cancer therapeutics. Based upon a greater understanding of the molecular aspects of cancer, new opportunities for therapeutic intervention have emerged that are effectively 'target orientated'. These new therapeutics are quite distinct from the classical chemotherapeutic agents and they offer the prospect of truly selective cancer therapies that are tailored towards the individual patient's tumour. Cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimental models and target orientated approaches.
The programme is designed to provide students with a 'state-of-the-art' course in modern cancer pharmacology that meets the demand of employers and provides an expert view of the available cancer medicines and the development of new cancer therapies.
It promotes advanced scholarship within specialised areas at the same time as the development of key transferable skills (in IT, communication, and time management) and research techniques. The taught component of the course provides the in-depth knowledge and skills necessary to work in cancer research, and is delivered across 2 semesters through lectures, workshops, practicals and 1-to-1 tutorials with ICT staff. Students will then join one of the research teams to complete the MSc research project.
| Level | Masters |
| Discipline | Sciences |
| Duration | 12 months |
| Intakes | Sep |
| Application Fees | GBP 0 |
| Tuition Fees | GBP 23028 |
| Campus | Main |
| Language proficiency (minimum) | |
| IELTS | 6 |
|---|---|
| TOEFL | 80 |
| PTE | 62 |
| Duolingo | Not Accepted |
| Exam proficiency (minimum) | |
| SAT | Not Required / Waiver |
|---|---|
| ACT | Not Required / Waiver |
| GRE | Not Required / Waiver |
| GMAT | Not Required / Waiver |
Minimum GPA - 70%
--
--
974
--
QS Quacquarelli Symonds is the world’s leading provider of services, analytics, and insight to the global higher education sector, whose mission is to enable motivated people anywhere in the world to fulfil their potential through educational achievement, international mobility, and career development.
THE (Times Higher Education) has been providing trusted performance data on universities for students and their families, academics, university leaders, governments and industry, since 2004. We create university rankings to assess university performance on the global stage and to provide a resource for readers to understand the different missions and successes of higher education institutions.
The Academic Ranking of World Universities (ARWU) was first published in June 2003 by the Center for World-Class Universities (CWCU), Graduate School of Education (formerly the Institute of Higher Education) of Shanghai Jiao Tong University, China, and updated on an annual basis
The "Webometrics Ranking of World Universities" is an initiative of the Cybermetrics Lab, a research group belonging to the Consejo Superior de Investigaciones Científicas (CSIC), the largest public research body in Spain. CSIC is among the first basic research organizations in Europe. The CSIC consisted in 2006 of 126 centers and institutes distributed throughout Spain.
